Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

188.63 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Here’s How Much You Would Have Made Owning ResMed Stock In The Last 20 Years ↗
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 1.89% on an annualized basis producing an average annual return ... 
Via Benzinga
News headline image
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
Check out the companies making headlines yesterday: Nubank (NYSE:NU): Digital banking platform Nubank (NYSE:NU) rose by 3.2% on Wednesday after the company r... 
Via StockStory
Topics Economy
News headline image
Why ResMed (RMD) Shares Are Falling Today
What Happened? Shares of medical device company ResMed (NYSE:RMD) fell 4.5% in the afternoon session after Morgan Stanley downgraded the stock to Equalweight... 
Via StockStory
Topics Artificial Intelligence Economy
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
ResMed Inc (NYSE:RMD): A Top Dividend Stock with Strong Profitability and Financial Health ↗
Via Chartmill
Wednesday's after hours session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
3 Big Reasons RMD Should Be On Your Watchlist
ResMed’s stock price has taken a beating over the past six months, shedding 26.3% of its value and falling to $185.29 per share. This may have investors wond... 
Via StockStory
News headline image
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS). 
From Resmed, Inc.
Via GlobeNewswire
Friday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
2 Healthcare Stocks to Research Further and 1 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloade... 
Via StockStory
ResMed (NYSE:RMD) Stock Dips Despite Q3 Earnings Beat and Strong Margin Growth ↗
Via Chartmill
Topics Earnings
News headline image
3 Large-Cap Stocks to Consider Right Now
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
From Resmed, Inc.
Via GlobeNewswire
News headline image
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
Oura Members can take action on changes in sleep or breathing patterns through educational resources from Resmed and pathways for accessing care 
From Resmed, Inc.
Via GlobeNewswire
News headline image
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions
ResMed’s first quarter saw the company deliver revenue and earnings above Wall Street expectations, yet the market responded negatively. Management attribute... 
Via StockStory
Topics Earnings Economy Retirement
These S&P500 stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
RMD Q1 Deep Dive: Mask Portfolio Drives Growth Amid Market Uncertainty and New CFO Appointment
Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 10.8% year on year to $1.43 bi... 
Via StockStory
Topics Economy Retirement
News headline image
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
News headline image
ResMed (RMD) Q3 2026 Earnings Transcript ↗
ResMed (RMD) Q3 2026 Earnings Transcript 
Via The Motley Fool
Top S&P500 movers in Thursday's after hours session ↗
Via Chartmill
News headline image
ResMed’s (NYSE:RMD) Q1 CY2026 Sales Beat Estimates
Medical device company ResMed (NYSE:RMD) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 10.8% year on year to $1.43 billion... 
Via StockStory
Topics Earnings
News headline image
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
From Resmed, Inc.
Via GlobeNewswire
News headline image
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
From Resmed, Inc.
Via GlobeNewswire
News headline image
ResMed Earnings: What To Look For From RMD
Medical device company ResMed (NYSE:RMD) will be announcing earnings results this Thursday afternoon. Here’s what to look for. ResMed beat analysts’ revenue ... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock Worth Investigating and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income ↗
ResMed Inc. offers a sustainable dividend with a 10-year growth history, backed by strong profitability, a low payout ratio, and a rock-solid balance sheet for durable passive income. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.